- Home
- SWBI vs CRMD Comparison
SWBI vs CRMD Comparison
Compare SWBI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SWBI | CRMD |
|---|---|---|
| Founded | 1852 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 637.4M | 590.7M |
| IPO Year | 2000 | 2009 |
Fundamental Metrics
Financial Performance| Metric | SWBI | CRMD |
|---|---|---|
| Price | $13.02 | $7.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $14.00 | ★ $14.83 |
| AVG Volume (30 Days) | 588.6K | ★ 1.1M |
| Earning Date | 06-17-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.37% | N/A |
| EPS Growth | 36.67 | ★ 780.00 |
| EPS | 0.06 | ★ 0.72 |
| Revenue | ★ $523,845,000.00 | $311,709,000.00 |
| Revenue This Year | $7.61 | $0.30 |
| Revenue Next Year | $3.72 | N/A |
| P/E Ratio | $219.17 | ★ $10.87 |
| Revenue Growth | 10.36 | ★ 617.03 |
| 52 Week Low | $8.14 | $6.13 |
| 52 Week High | $17.56 | $13.02 |
Technical Indicators
Market Signals| Indicator | SWBI | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 44.97 |
| Support Level | $12.09 | $7.09 |
| Resistance Level | $15.60 | $9.01 |
| Average True Range (ATR) | 0.52 | 0.25 |
| MACD | 0.07 | -0.07 |
| Stochastic Oscillator | 54.58 | 14.24 |
Price Performance
Historical ComparisonAbout SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based company engaged in manufacturing and selling firearms. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The company sells its products under the Smith and Wesson and Gemtech brands, which are used for defense, law enforcement, hunting, and sporting purposes. Geographically, it sells products globally, with maximum income being generated by the U.S. market from its handgun products.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.